(Q61900303)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10631456%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Neo-adjuvant chemotherapy and bladder preservation in locally advanced transitional cell carcinoma of the bladder (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10631456%20AND%20SRC:MED&resulttype=core&format=json

transitional cell carcinoma

3 November 2019

main subject

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10631456%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Diana Giannarelli

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10631456%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

C N Sternberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10631456%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

V Pansadoro

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10631456%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

L Marini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10631456%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A van Rijn

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10631456%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

P D Carli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10631456%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A Platania

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10631456%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A Rossetti

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10631456%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 November 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10631456%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10631456%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10631456%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

1301-1305

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10631456%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10631456%20AND%20SRC:MED&resulttype=core&format=json

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350518083

7 January 2021

Neo-adjuvant chemotherapy for invasive bladder cancer. Experience with the M-VAC regimen

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350518083

7 January 2021

Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350518083

7 January 2021

Bladder preservation by combined modality therapy for invasive bladder cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350518083

7 January 2021

Neoadjuvant m-vac (methotrexate, vinblastine, doxorubicin, and cisplatin) for infiltrating transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350518083

7 January 2021

Staging invasive bladder tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350518083

7 January 2021

Neoadjuvant and adjuvant chemotherapy in advanced disease--what are the effects on survival and prognosis?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350518083

7 January 2021

Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350518083

7 January 2021

Conservative management of muscle-infiltrating bladder cancer: prospective experience.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350518083

7 January 2021

Feasibility of transurethral resection for muscle infiltrating carcinoma of the bladder: long-term followup of a prospective study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350518083

7 January 2021

Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-up.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350518083

7 January 2021

Neoadjuvant chemotherapy in invasive bladder cancer: the evolving role of surgery.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350518083

7 January 2021

Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350518083

7 January 2021

Identifiers

DOI

10.1023/A:1008350518083

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10631456%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference